Doceright 120 mg contains docetaxel, a chemotherapy medicine that plays a key role in treating several types of solid tumors. It is part of a group of medications known as taxanes, which are known for slowing down or stopping cancer cell growth. Administered through intravenous infusion under medical supervision, Doceright is often used when cancers have spread or become resistant to other forms of treatment. Its strength and effectiveness make it a commonly chosen option in many oncology protocols.

Mechanism of Action

Docetaxel works by targeting the internal structure of cells, specifically the microtubules, which are essential for cell division. During the normal cell cycle, microtubules help the cell divide and replicate. Docetaxel binds to these structures and stabilises them, preventing their breakdown. This disruption halts the ability of the cancer cells to multiply, ultimately leading to their death. It is particularly effective against fast-growing tumors that rely on rapid cell division.

Uses

Doceright 120 mg is used in the treatment of several types of cancer, including:

• Breast cancer

• Non-small cell lung cancer

• Prostate cancer (especially in cases that are advanced or resistant to hormonal therapy)

• Stomach (gastric) cancer

• Head and neck cancers

  Adverse Effects

  Common side effects

  • Fatigue or weakness

  • Nausea and vomiting

  • Diarrhea

  • Temporary hair loss

  • Mouth sores

  • Nail changes

  • Low blood counts, leading to higher risk of infections